Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,152.40$ +1.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Eli Lilly and Company (LLY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 142,283 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LLY
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	57,916	64,006	63,944	71,875	75,607	78,715	89,389	100,923	114,935	112,476	116,576	142,283
Current Assets	23,007	25,727	25,189	30,204	31,415	32,740	41,261	49,854	62,071	55,629	54,835	64,672
Cash	2,381	2,819	2,460	3,224	3,369	3,268	3,093	3,376	9,792	7,163	5,136	8,890
Cash & Short-Term Investments	2,494	2,928	2,586	3,364	3,518	3,423	3,221	3,546	9,914	7,268	5,282	8,950
Receivables	10,364	11,336	10,014	13,079	12,052	13,275	14,003	17,206	19,457	20,155	21,177	23,475
Inventory	4,901	5,773	6,102	6,482	7,460	7,589	9,311	11,014	12,180	13,744	14,529	16,793
Property, Plant & Equipment	11,863	–	–	–	16,172	17,102	18,474	20,530	22,316	24,675	–	–
Goodwill	4,085	4,940	4,940	5,768	5,768	5,770	5,771	5,771	5,898	5,898	6,130	8,849
Intangible Assets	6,782	6,907	6,762	6,636	6,537	6,166	6,012	5,908	6,447	6,522	7,374	18,110
Total Liabilities	46,608	53,143	51,046	58,239	61,286	64,443	73,542	82,574	91,085	85,941	85,378	108,404
Current Liabilities	21,998	27,293	18,598	27,121	24,674	28,377	30,068	39,020	40,141	35,228	36,634	47,741
Short-Term Debt	2,245	6,905	1,652	5,162	2,074	5,117	4,016	5,724	1,633	1,635	4,000	7,050
Accounts Payable	2,435	2,599	2,474	2,925	2,887	3,229	3,442	4,076	4,262	5,379	5,029	6,112
Long-Term Debt	17,924	18,321	24,560	23,730	29,045	28,527	34,500	34,180	40,874	40,868	39,370	47,858
Shareholders' Equity	11,220	10,772	12,812	13,562	14,240	14,192	15,765	18,273	23,793	26,535	31,198	33,879
Retained Earnings	10,310	10,312	12,554	13,178	13,627	13,545	15,100	17,376	22,252	24,470	29,514	31,893
Shares Outstanding	949	904	904	904	905	903	901	900	899	898	896	894

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings